Picture of ConvaTec logo

CTEC ConvaTec News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

REG - Convatec Group PLC - Director/PDMR Shareholding

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250904:nRSD0930Ya&default-theme=true

RNS Number : 0930Y  Convatec Group PLC  04 September 2025

4 September 2025

Convatec Group Plc

("Convatec" or "the Company")

 

Director/PDMR Shareholding

 

Exercise of options - "Save As You Earn" share option scheme

 

The Company has been notified of the following transactions in relation to
Persons Discharging Managerial Responsibility ("PDMR") in respect of ordinary
shares of 10 pence each in the Company ("Shares").

 

Following the appointment of Fiona Ryder on 4 August 2025 as Interim Chief
Financial Officer and PDMR, we have been notified that on 2 September 2025,
Ms. Ryder exercised options over 10,346 Shares. The options were granted on 14
July 2022 under the Convatec 2017 Save as You Earn scheme, at an option price
of 173.97 pence per Share.

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

 Details of the person discharging managerial responsibilities / person closely
 associated
 Name                                                         Fiona Ryder

 Reason for the notification

 Position/status                                              Interim Chief Financial Officer and PDMR

 Initial notification /Amendment                              Initial notification

 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Convatec Group Plc

 LEI                                                          213800LS272L4FIDOH92

 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted

 Description of the financial instrument, type of instrument  Ordinary shares of 10p each in Convatec Group Plc

 Identification code                                          GB00BD3VFW73

 Nature of the transaction                                    Exercise of options granted under the Convatec Group Plc 2017 Save As You Earn
                                                              scheme
 Price(s) and volume(s)

Price(s)   Volume(s)
                                                              £ 1.7397   10,346

 Aggregated information

 - Aggregated volume                                          N/A - single transaction

 - Price

 Date of the transaction                                      2 September 2025

 Place of the transaction                                     Outside a trading venue

Aggregated information

- Aggregated volume

N/A - single transaction

- Price

Date of the transaction

 

2 September 2025

Place of the transaction

 

Outside a trading venue

 

Contacts

The person responsible for making this announcement is James Kerton, Company
Secretary, Convatec Group plc: cosec@convatec.com

 

Media: MediaRelations@convatec.com

 

Investor Relations: IR@convatec.com

 

Convatec Group Plc's LEI code is 213800LS272L4FIDOH92

 

Classification: 2.2 Information disclosed under article 19 of the Market Abuse
Regulation

 

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than
10,000 colleagues, we provide our products and services in around 90
countries, united by a promise to be forever caring. Our solutions provide a
range of benefits, from infection prevention and protection of at-risk skin,
to improved patient outcomes and reduced care costs. Convatec's revenues in
2024 were over $2 billion. The company is a constituent of the FTSE 100 Index
(LSE:CTEC). To learn more please visit http://www.convatecgroup.com
(http://www.convatecgroup.com)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFEASISIIE

Recent news on ConvaTec

See all news